scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1111/1440-1681.12858 |
P8608 | Fatcat ID | release_dirhlu5h2jc2bhx2tqvvdigj6m |
P698 | PubMed publication ID | 28945935 |
P50 | author | Shanxin Liu | Q95951045 |
P2093 | author name string | Bin Ni | |
Xingwei Zhang | |||
Donglai Zhou | |||
Yunyan Jing | |||
P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity | Q28196405 | ||
Ticagrelor versus clopidogrel in patients with acute coronary syndromes | Q29619002 | ||
Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome | Q37103506 | ||
P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. | Q37562606 | ||
Efficacy and safety analysis of new P2Y12 inhibitors versus clopidogrel in patients with percutaneous coronary intervention: a meta-analysis | Q38592255 | ||
Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO study. | Q40533249 | ||
High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-centre trial | Q40595293 | ||
Ticagrelor vs. clopidogrel in non-ST-elevation acute coronary syndromes | Q41158103 | ||
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes | Q46916589 | ||
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE | Q46916592 | ||
Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes. | Q53480416 | ||
Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison. | Q54600153 | ||
P433 | issue | 2 | |
P921 | main subject | acute coronary syndrome | Q266018 |
P304 | page(s) | 122-126 | |
P577 | publication date | 2017-09-25 | |
P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
P1476 | title | Efficacy and safety of ticagrelor in patients with acute coronary syndrome: A meta-analysis of randomized controlled trials | |
P478 | volume | 45 |
Search more.